Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
02/2014
02/12/2014CN103582643A 蛋白激酶抑制剂 Protein kinase inhibitors
02/12/2014CN103570793A Bile acid type compound, intermediate, preparation method and application of bile acid type compound
02/12/2014CN103570782A Nano molecular probe FMAU precursor, and preparation method thereof
02/11/2014US8648170 Peptide-presenting surfaces for long-term culture of pluripotent cells
02/11/2014US8647826 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
02/11/2014US8647636 Low antigen-dose immunization utilizing overlapping peptides for maximizing T-helper cell 1 (Th1) immunity against a pathogen
02/11/2014US8647603 Devices and methods for the treatment of cancer
02/11/2014CA2623554C Methods and therapies for treating inflammatory conditions with exposed collagen
02/11/2014CA2605763C A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
02/11/2014CA2531894C Inherently radiopaque polymeric products for embolotherapy
02/11/2014CA2529496C Anti-cd74 immunoconjugates and methods
02/11/2014CA2421751C Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
02/06/2014WO2014022807A2 Compositions and methods of using the compositions for plaque softening
02/06/2014WO2014022741A1 Paa nanoparticles for pet imaging and pdt treatment
02/06/2014US20140039153 Cancer imaging and treatment
02/06/2014US20140037544 Labeled iodinated tropane formulation
02/06/2014US20140037543 Anti-Pancreatic Cancer Antibodies
02/06/2014US20140037541 Radioimaging methods using teboroxime and thallium
02/06/2014US20140037539 Antibody cocktails for breast cancer radioimmunotherapy
02/05/2014EP2691122A2 Pharmaceutical preparation comprising alpha emitting radionuclide
02/05/2014EP2691120A2 Theranostic imaging agents and methods of use
02/05/2014CN103561776A Radiolabelled glutaminyl cyclase inhibitors
02/05/2014CN103550797A Application of 99mTc labeling T7 and T7-6H serving as integrin alpha nu beta 3 receptor imaging agent and achievement method
02/05/2014CN103550796A Method for preparing iodine-125 sealed seed source core
02/04/2014US8642561 Peptides whose uptake by cells is controllable
02/04/2014US8642028 Recombinant adenoviruses encoding the specific iodine transporter (NIS)
02/04/2014US8642010 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
02/04/2014US8642008 Molecular probe for imaging of pancreatic islets and use of the same
02/04/2014US8642007 Method and compound for treatment of cancer using phosphorous-32 labeled DNA
02/04/2014US8641903 Method for the preparation of reactive [18] F fluoride
02/04/2014CA2770489C Bisphosphonate conjugates and methods of making and using the same
02/04/2014CA2672914C Process for production of precursor compound for radioactive halogen-labeled organic compound
02/04/2014CA2432797C Local regional chemotherapy and radiotherapy using in situ hydrogel
01/2014
01/30/2014US20140030263 Treatment of diffuse large-cell lymphoma with anti-cd20 antibody
01/30/2014US20140030191 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
01/30/2014US20140030190 Labelled and un-labelled methyl-pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
01/30/2014US20140030189 Ligands for imaging cardiac innervation
01/30/2014US20140030188 Process for production of heterodimers of glutamic acid
01/30/2014US20140030187 Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
01/29/2014EP2688901A1 INHIBITORS OF 17ß-HSD1, 17ß-HSD3 AND 17ß-HSD10
01/29/2014CN103547291A Technetium labelled peptides
01/29/2014CN103537239A Small-volume [<18>F] fluorine isotope labeled reactor and application thereof
01/28/2014US8637635 Peptides that selectively home to heart vasculature and related conjugates and methods
01/28/2014US8636981 Detection of amyloid deposits using anti-amyloid antibodies
01/28/2014US8636978 Cyclized NGR peptide compounds, compositions, and methods of their use
01/28/2014US8636977 Integrin targeted synthetic ligands for diagnostic and therapeutic applications
01/28/2014CA2599734C Humanized l243 antibodies
01/28/2014CA2538192C Improved process for the production of a radioactive aerosol
01/28/2014CA2530789C Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
01/28/2014CA2510315C Antibodies against gpr64 and uses thereof
01/23/2014WO2014012997A1 Composition for therapeutic use, including an organic lipid phase and a rare- earth radioisotope complex
01/23/2014WO2013181597A3 Thiol-ene click chemistry for drug conjugates
01/23/2014WO2013173004A8 Radiopharmaceutical synthesis methods
01/23/2014US20140024953 Breath test device and method
01/23/2014US20140024631 Steroids as Agonists for FXR
01/23/2014US20140024604 Glycopeptide phosphonate derivatives
01/23/2014US20140023587 Phospholipid analogs as diapeutic agents and methods thereof
01/23/2014US20140023586 Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran
01/23/2014US20140023585 177 lutetium-labeled bombesin analogs for radiotherapy
01/23/2014US20140023583 Method of measuring and comparing levels of substances in an individual's body
01/22/2014EP2687539A1 Annexin v variant, and preparation and use thereof
01/22/2014CN103534253A Novel compound having affinity for amyloid
01/22/2014CN103533963A HER2 binding peptides labeled with aluminium-[18] fluoride complexed by nota
01/22/2014CN103524506A Preparation method and application of radioiodine labeled biomolecules
01/21/2014US8632991 Methods and compositions for treating bleeding disorders
01/21/2014US8632748 Compositions of high specific activity 117mSn and methods of preparing the same
01/21/2014CA2604034C Improved stably tethered structures of defined compositions with multiple functions or binding specificities
01/21/2014CA2478047C Rs7 antibodies
01/21/2014CA2418014C Immunotherapy for chronic myelocytic leukemia
01/16/2014WO2014011327A1 Radiolabeled probes for the non-invasive detection and imaging of cell death
01/16/2014WO2014009496A1 Cancer treatment
01/16/2014US20140017168 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules
01/16/2014US20140017167 Anti-IL1RAP Antibodies and Their Use for Treating Human
01/15/2014EP2683386A2 Compounds and methods of use in ablative radiotherapy
01/14/2014US8628750 Cancer imaging and treatment
01/14/2014CA2439925C Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
01/09/2014WO2014006022A1 Glycoside derivatives, preparation thereof and use thereof as prosthetic groups
01/09/2014US20140010758 Peptidomimetic inhibitors of psma
01/09/2014US20140010757 Imaging methods using engineered integrin binding peptides
01/09/2014US20140010755 Multi-encapsulated formulations made with oxidized cellulose
01/08/2014EP2680889A1 Radiolabelled octreotate analogues as pet tracers
01/08/2014EP2680888A1 Technetium labelled peptides
01/08/2014EP2510951A9 Molecular probe for imaging of pancreatic islet, and use thereof
01/08/2014CN103501825A Ultrafiltration concentration of allotype selected antibodies for small-volume administration
01/08/2014CN103497235A Small molecular peptide probe and preparation method and application thereof
01/08/2014CN103497217A 2-aryl benzothiazole compound with high affinity with A(beta) plaque and preparation method and application thereof
01/08/2014CN103495188A Medical polymer material with radioactive nuclide marker, and preparation method as well as application thereof
01/08/2014CN103495169A Methods and compositions for treatment and control of multiple myeloma
01/08/2014CN103494817A Methods and compoistions used for treatment and control of multiple myeloma
01/08/2014CN102219818B Thymidine derivates as well as preparation method and applications thereof in preparing tumor developing agents as ligand
01/07/2014US8623349 Systems, methods and microrganisms for antibody production with type III secretion system
01/07/2014US8623326 Ghrelin analogues
01/07/2014US8623324 Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
01/07/2014US8623323 Thickened beverages for dysphagia
01/07/2014US8623322 Non-invasive diagnostic agents and methods of diagnosing infectious disease
01/07/2014US8622920 Breath test device and method
01/07/2014CA2546675C Pharmaceutical formulations for the sustained release of one or more active principles and applications thereof, such as therapeutic applications
01/07/2014CA2464472C Antibody targeting compounds
01/03/2014WO2014001538A1 Imaging fibrosis
01/03/2014WO2013173716A3 Methods for diagnosing and monitoring eosinophilic esophagitis
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 243